Clin2
NCT07357922Possibly a fitNot yet recruiting

Progesterone and threatened miscarriage during breastfeeding

Threatened Abortion

Part of Women’s health & pregnancy clinical trials.

This study looks at how progesterone levels relate to threatened miscarriage in women who become pregnant while breastfeeding. It aims to help understand and manage this situation better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years to 50 years
Study type
Observational

Who can take part

  • You are a woman between 18 and 50 years old.
  • You became pregnant while you were still breastfeeding.
  • You are pregnant with one baby (not twins or more).
  • You are in your first trimester (first 12 weeks of pregnancy).
  • You have a blood test for progesterone from your routine checkup.
  • You do not have any long-term medical conditions (like diabetes or high blood pressure).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06123026Recruiting· Phase 4
Medication to stop breast milk after 16–20 week abortion

This study tests a medication given after a second-trimester abortion (16–20 weeks) to see if it can safely and effectively stop the body from producing breast milk. It also wants to learn how well people tolerate the medicine.

Chicago, Illinois
NCT04783857Recruiting· Phase 4
Hormone therapy to prevent smoking relapse after childbirth

This trial tests whether giving progesterone after childbirth can help new mothers stay quit from smoking, reducing secondhand smoke exposure to their babies. It's for women who smoked before pregnancy and want to remain smoke-free after delivery.

Minneapolis, Minnesota
NCT07448597Recruiting· Phase 4
Progesterone for preventing preeclampsia

This trial tests if taking progesterone early in pregnancy can help prevent preeclampsia, a condition of high blood pressure. You may qualify if you are over 18, speak English, and are less than 12 weeks pregnant.

Charleston, South Carolina
NCT07136922Recruiting· Phase 1
Testing a new progesterone tablet for luteal phase issues

This trial tests a new progesterone tablet (Callavid) to see if it is safe and easy to use for women with a short or weak luteal phase (the time after ovulation). It may help support early pregnancy and reduce the risk of miscarriage.

Coventry
NCT05787509Recruiting· Phase 4
Progesterone to help prevent early delivery after IVF

This trial tests whether taking progesterone for longer during an IVF pregnancy can help lower the risk of preterm birth (birth too early). It is for people who are pregnant from a fresh embryo transfer of a single embryo.

Guangzhou
NCT07028710Recruiting
Progesterone changes after hCG-triggered ovulation in natural cycles

This study looks at how progesterone levels change in the early part of the luteal phase (after ovulation) when ovulation is triggered by an hCG injection in a natural cycle. It may help women undergoing routine ovulation induction understand how their body responds.

Montpellier

Hear when a new Threatened Abortion trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.